Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
F-18 fluorodeoxyglucose imaging in myocardial ischemia: Beyond myocardial viability
Author
James A. Arrighi
Publication date
01-05-2001
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2001
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1067/mnc.2001.115646

Other articles of this Issue 3/2001

Journal of Nuclear Cardiology 3/2001 Go to the issue

OriginalPaper

Myocardial perfusion and angiographic correlations in patients with ST-segment elevation during dobutamine stress perfusion imaging

OriginalPaper

Cardiac receptor physiology and its application to clinical imaging: present and future

Editor’s Page

Cross training

OriginalPaper

Detection of a large substernal goiter during Tc-99m tetrofosmin cardiac SPECT imaging

Original Articles

Failure of right precordial electrocardiography during stress testing to identify coronary artery disease

OriginalPaper

The influence of attenuation and scatter compensation on the apparent distribution of Tc-99m sestamibi in cardiac slices

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits